Indutrade (INDT) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jan, 2026Executive summary
Achieved solid financial performance in 2024, with revenue reaching SEK 32.5 billion, up 2% year-over-year, and a stable EBITA margin of 14.4%, supported by a diversified structure and resilience in a weaker business climate.
Completed 16 acquisitions in 2024, adding SEK 1.6 billion in annual turnover, with a strong pipeline and continued focus on sustainable, profitable growth.
Board proposes a dividend increase to SEK 3.00 per share, up from SEK 2.85.
Climate targets validated by the Science Based Targets initiative, aiming for a 50% reduction in Scope 1 & 2 emissions and 25% in Scope 3 by 2030, and net zero by 2050.
Record-high operational cash flow in Q4 at SEK 1,599 million; full-year operational cash flow SEK 4,134 million.
Financial highlights
Net sales grew 2% year-over-year to SEK 32.5 billion; Q4 net sales up 7% (2% organic); Q4 order intake flat, with a 5% organic decline.
EBITA margin for 2024 at 14.4%; Q4 EBITA margin stable at 14.6% (14.3% excluding one-offs).
Gross margin improved to 35.7% in Q4; full-year gross margin at 35.0%.
EPS for Q4 increased 3% to SEK 2.01; full-year EPS at SEK 7.55, down from SEK 7.86 in 2023.
Net debt/EBITDA stable at 1.4x; net debt/equity at 49% (down from 53%).
Outlook and guidance
Market uncertainty expected to persist in coming quarters, with a slightly lower order backlog but positive macroeconomic trends and strong long-term prospects in key sectors.
Life Science and Process, Energy and Water segments expected to perform well in 2025; acquisition pipeline remains robust.
Infrastructure and Construction expected to see profitability improvement in 2025 after restructuring.
New segment-based group structure to support continued organic and acquisition-driven growth.
Latest events from Indutrade
- Doubling in size targeted through disciplined acquisitions, sector focus, and strong financial targets.INDT
CMD 20253 Feb 2026 - Order intake rose 2% and acquisitions boosted growth, despite a 1% sales decline.INDT
Q4 20253 Feb 2026 - Record sales and margins driven by Life Science and acquisitions, despite softer cash flow.INDT
Q2 20243 Feb 2026 - Decentralized growth, sector focus, and strong cash flow drive sustained profitability.INDT
SEB Nordic Seminar presentation22 Jan 2026 - Q3 2024 saw stable growth, strong margins, and continued acquisition activity.INDT
Q3 202418 Jan 2026 - EBITA up 6% to SEK 1,094m, margin 13.6%, led by Life Science and acquisitions.INDT
Q1 202524 Dec 2025 - Order intake up 3% y/y, strong margins, and ten acquisitions drive growth despite market headwinds.INDT
Q3 202521 Oct 2025 - Stable order intake, lower sales and profit, but strong acquisition pipeline and resilient margins.INDT
Q2 202515 Jul 2025